Nasdaq Most Active

Prism Marketview
  • Home
  • Indexes
    • All Indexes
    • Aerospace and Defense
    • AI Datacenter and Infrastructure
    • Biotech
    • Cannabis
    • Comms and Media
    • Consumer Products
    • Cybersecurity
    • Crypto Mining
    • EV
    • Fintech
    • Global Health
    • Healthcare
    • MedDevices
    • Mental Health
    • New Energy
    • NextGen Tech & AI
    • Oil & Gas
    • Pet Care
    • Pharmaceuticals
    • Precious Metals
    • Psychedelics
    • Semiconductors
    • Space
    • Sports
    • Weight Loss
    • Wellness
    • Women?s Health
  • Companies
  • Trending News
    • PRISM View
    • Biotech
    • Finance
    • Healthcare
    • Technology
    • Login
    • User Profile
    • Log Out
  • Home
  • Indexes
    • All Indexes
    • Aerospace and Defense
    • AI Datacenter and Infrastructure
    • Biotech
    • Cannabis
    • Comms and Media
    • Consumer Products
    • Cybersecurity
    • Crypto Mining
    • EV
    • Fintech
    • Global Health
    • Healthcare
    • MedDevices
    • Mental Health
    • New Energy
    • NextGen Tech & AI
    • Oil & Gas
    • Pet Care
    • Pharmaceuticals
    • Precious Metals
    • Psychedelics
    • Semiconductors
    • Space
    • Sports
    • Weight Loss
    • Wellness
    • Women?s Health
  • Companies
  • Trending News
    • PRISM View
    • Biotech
    • Finance
    • Healthcare
    • Technology
    • Login
    • User Profile
    • Log Out

Home Cardiovascular

Tag: Cardiovascular

Medical illustration highlighting a blood clot in the lungs, representing pulmonary embolism and research into thrombectomy treatment outcomes.
October 02, 2026

AngioDynamics Backs Jacobi Hospital Study to Predict Pulmonary Embolism Thrombectomy Success

Key Points AngioDynamics and The PERT Consortium selected Jacobi Hospital in the Bronx, New York, for an ALPHA-PE Research Fund award. The independent, investigator-led study…

April 24, 2026

Nanosecond Pulses, Billion‑Dollar Market: Pulse Biosciences’ nsPFA Tech Takes Aim at AFib Heavyweights

Pulse Biosciences (NASDAQ: PLSE) is leaning hard into the pulsed‑field ablation (PFA) arms race, and its latest data suggest its nanosecond PFA platform (nsPFA) may…

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup

News

  • Latest
  • PRISM View
  • Biotech
  • Finance
  • Healthcare
  • Technology

Indexes

  • Aerospace & Defense
  • AI Datacenter and Infrastructure
  • Biotech
  • Cannabis
  • Comms and Media
  • Consumer Products
  • Crypto Mining
  • Cybersecurity
  • EV
  • Fintech
  • Global Health
  • Healthcare
  • MedDevices
  • Mental Health
  • New Energy
  • NextGen Tech & AI
  • Oil & Gas
  • Pet Care
  • Pharmaceuticals
  • Psychedelics
  • Semiconductors
  • Space
  • Sports
  • Weight Loss
  • Wellness
  • Women’s Health
  • Home
  • About Us
  • Contact Us

Copyright © 2026 PRISM MarketView. All rights reserved.

  • Terms & Conditions
  • Privacy Policy
  • Disclaimer